These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Leaning towards Cytomegalovirus serological screening in pregnancy to prevent congenital infection: a cost-effectiveness perspective. Seror V, Leruez-Ville M, Ӧzek A, Ville Y. BJOG; 2022 Jan; 129(2):301-312. PubMed ID: 34651405 [Abstract] [Full Text] [Related]
5. Cytomegalovirus Screening in Pregnancy: A Cost-Effectiveness and Threshold Analysis. Albright CM, Werner EF, Hughes BL. Am J Perinatol; 2019 Jun; 36(7):678-687. PubMed ID: 30567003 [Abstract] [Full Text] [Related]
9. Case report on early treatment with valaciclovir after maternal primary cytomegalovirus infection. Codaccioni C, Vauloup-Fellous C, Letamendia E, Saada J, Benachi A, Vivanti AJ. J Gynecol Obstet Hum Reprod; 2019 Apr; 48(4):287-289. PubMed ID: 30634004 [Abstract] [Full Text] [Related]
16. Screening and treating for primary cytomegalovirus infection in pregnancy: where do we stand? A decision-analytic and economic analysis. Cahill AG, Odibo AO, Stamilio DM, Macones GA. Am J Obstet Gynecol; 2009 Nov; 201(5):466.e1-7. PubMed ID: 19782961 [Abstract] [Full Text] [Related]
17. Prevention of Congenital Cytomegalovirus Infection: Review and Case Series of Valaciclovir versus Hyperimmune Globulin Therapy. Nigro G, Muselli M, On Behalf Of The Congenital Cytomegalic Disease Collaborating Group. Viruses; 2023 Jun 15; 15(6):. PubMed ID: 37376675 [Abstract] [Full Text] [Related]
20. Combined treatment with immunoglobulin and valaciclovir in pregnant women with cytomegalovirus infection and high risk of symptomatic fetal disease. De la Calle M, Baquero-Artigao F, Rodríguez-Molino P, Cabanes M, Cabrera M, Antolin E, Mellado MJ, Bartha JL. J Matern Fetal Neonatal Med; 2022 Aug 15; 35(16):3196-3200. PubMed ID: 32933353 [Abstract] [Full Text] [Related] Page: [Next] [New Search]